Intel's contract chipmaking division is reportedly in advanced discussions with tech giants Nvidia and Apple to manufacture key components starting in 2028, a potential game-changer for the semiconductor industry's supply chain.
Medtronic secures a key European regulatory nod for its latest pulsed field ablation catheter while deepening its collaboration with Mindray, signaling a strategic push into high-growth areas of cardiac care and ambulatory surgery.
American Express reported a 10.6% year-over-year revenue increase to $17.57 billion for the fourth quarter of 2025, yet missed Wall Street's sales expectations. Earnings per share of $3.53 met analyst consensus estimates.
Mizuho Securities raised its rating on Applied Materials (AMAT) to Outperform, with a $370 price target, forecasting accelerated growth in global wafer fab equipment spending driven by major chipmakers' capital expenditure plans.
Coinbase CEO Brian Armstrong announces the company will match the U.S. government's $1,000 'Trump Accounts' contribution for eligible children of employees, with a preference to execute the match in Bitcoin, highlighting crypto's growing intersection with federal policy initiatives.
The long-term strategic partnership will leverage IQVIA's data-as-a-service platform to unify and streamline commercial data across 59 countries, aiming to accelerate product launches and enhance decision-making for the pharmaceutical giant.
German automotive giant Bosch reports a sharp 45% drop in operating profit for 2025, driven by heavy restructuring charges, intense global competition, and delayed returns on future-tech investments.
Elon Musk is reportedly in early-stage talks to merge his flagship companies—SpaceX, Tesla, and xAI—into a single, trillion-dollar technology and infrastructure behemoth ahead of a potential SpaceX IPO, sources familiar with the matter indicate.
In a bold bid to reclaim semiconductor leadership, Intel is aggressively deploying ASML's next-generation lithography systems years ahead of rival TSMC. The 2026 timeline is critical for the chipmaker's turnaround plan.
BEN finalizes a landmark AI licensing framework for Africa and a university wellbeing pilot while bolstering its balance sheet through capital raises and debt conversion, prompting analysts to question if execution is now the priority.
The new campus in McBee, SC, aims to bolster North American supply chains for critical minerals, starting with a 2,000-ton annual processing capacity for magnet scrap.
Bitcoin's sharp retreat to $81,000 on Thursday, following the Federal Reserve's latest policy announcement, resulted in massive leveraged position liquidations and sent shockwaves through correlated equities.
A routine commute in Minneapolis turns into a biometric checkpoint, spotlighting the advanced surveillance tools—from facial recognition apps to vast data networks—now central to federal immigration enforcement. As operations intensify, questions mount over privacy, oversight, and the line between targeted enforcement and dragnet surveillance.
A deep dive into Kadant Inc.'s intrinsic value using a Discounted Cash Flow model suggests the stock is trading near its estimated fair value of $273, raising questions about its near-term upside potential amid current market prices.
Despite recent market turbulence, a surge in eurozone business confidence is spotlighting companies where high insider ownership aligns management with shareholder interests. We examine three such firms poised for growth.
In a bold strategic pivot, cryptocurrency giant Binance announced it will convert its entire $1 billion SAFU emergency reserve from stablecoins to Bitcoin over the next month, a move seen as both a vote of confidence in BTC and a potential gamble on user protection funds.
Prime Minister Keir Starmer's landmark visit to Beijing marks a cautious pivot in UK-China relations, yielding agreements on tariffs, visas, and green energy. But can British businesses navigate the opportunities and challenges of re-engagement?
Waste Management capped off a strong 2025 with record cost performance and margin expansion, driven by operational discipline and its growing sustainability portfolio. The company forecasts continued growth for 2026, backed by robust cash flow and ambitious capital return plans.
The Horatio Alger Award bestowed upon ResMed founder Dr. Peter Farrell underscores the company's decades-long leadership in sleep and respiratory care, bringing its financial performance and competitive strategy into sharper focus for investors.
The medical technology giant reported double-digit organic sales growth and robust profitability for 2025, driven by record installations of its Mako surgical robots. While projecting continued strength for 2026, management acknowledged incremental tariff pressures but expressed confidence in the company's ability to sustain margin expansion.
